{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:51:17Z","timestamp":1791571877344,"version":"4.3.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>IgG4-related dacryoadenitis is an ocular manifestation of IgG4-related disease. Reports on its multimodal imaging features, particularly the manifestations on color Doppler ultrasound, are rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 76-year-old woman experienced persistent edema of the bilateral upper eyelids for more than 2 years, with a medical history of vitiligo, allergic dermatitis, and hypertension. Physical examination revealed enlarged lacrimal glands with palpable, firm, and movable nodules, accompanied by swollen eyelids and swollen lymph nodes in front of the ears. Color Doppler ultrasound showed the lacrimal glands were markedly enlarged bilaterally, rich in blood supply. Orbital computed tomography highlighted diffuse enlargement of the lacrimal glands bilaterally, with slightly higher density. Serum IgG4 levels were elevated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>IgG4 related dacryoadenitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>A biopsy of left lacrimal gland was performed and methylprednisolone 20\u2009mg\/day was prescribed and then tapered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Her symptoms improved significantly 1 week after treatment. Serum IgG4 levels gradually decreased. At the 6-month follow-up, the condition was stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>IgG4-related dacryoadenitis should be considered in the differential diagnosis of unexplained lacrimal gland enlargement. The association between IgG4-related dacryoadenitis and concurrent vitiligo requires further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047892","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:02:15Z","timestamp":1773043335000},"page":"e47892","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The clinical and multimodal imaging features of IgG4-related dacryoadenitis with coexisting vitiligo: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-2129","authenticated-orcid":false,"given":"Tian","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/mr\/roae096","article-title":"The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.","volume":"35","author":"Kanda","year":"2025","journal-title":"Mod Rheumatol"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jcu.23187","article-title":"Ultrasound imaging in orbital mucosa-associated lymphoid tissue lymphoma with IgG-4 positive.","volume":"50","author":"Song","year":"2022","journal-title":"J Clin Ultrasound"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40477-020-00443-0","article-title":"The role of ultrasonography in differential diagnosis of orbital lesions.","volume":"24","author":"Lanni","year":"2021","journal-title":"J Ultrasound"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-015-0751-x","article-title":"Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz\u2019s disease) and for differentiating it from Sj\u00f6gren\u2019s syndrome (SS), with an emphasis on sonography.","volume":"17","author":"Shimizu","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14397595.2019.1576271","article-title":"The diagnostic utility of submandibular gland sonography and labial salivary gland biopsy in IgG4-related dacryoadenitis and sialadenitis: Its potential application to the diagnostic criteria.","volume":"30","author":"Sakamoto","year":"2020","journal-title":"Mod Rheumatol"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/1756-185X.14521","article-title":"Orbital inflammatory pseudotumor revealing multi-organ immunoglobulin G4-related disease.","volume":"26","author":"Ben Salah","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease.","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet (London, England)"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo.","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet (London, England)"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","article-title":"IgG4-related disease in the Japanese population: a genome-wide association study.","volume":"1","author":"Terao","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1468-3083.2010.03971.x","article-title":"Comparisons of clinical features of HLA-DRB1*07 positive and negative vitiligo patients in Chinese Han population.","volume":"25","author":"Hu","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease.","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/aos.14048","article-title":"The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature.","volume":"97","author":"Detiger","year":"2019","journal-title":"Acta Ophthalmologica"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"21337","DOI":"10.18632\/oncotarget.25095","article-title":"IgG4-related kidney disease: the effects of a rituximab-based immunosuppressive therapy.","volume":"9","author":"Quattrocchio","year":"2018","journal-title":"Oncotarget"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3390\/jcm13143998","article-title":"Treatment outcomes of patients with orbital inflammatory diseases: should steroids still be the first choice?","volume":"13","author":"Al-Ghazzawi","year":"2024","journal-title":"J Clin Med"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12348-021-00253-3","article-title":"Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease.","volume":"11","author":"Ng","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.006","article-title":"Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis.","volume":"127","author":"Liu","year":"2024","journal-title":"Eur J Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:08:49Z","timestamp":1791569329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047892","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}